EMP3 promotes tumor growth and metastasis through the PI3K/AKT pathway, and is highly expressed in upper urinary tract urothelial carcinoma (UTUC) and hepatocellular carcinoma (HCC) [16,17]. Here, AKT1 is linked to hepatocellular carcinoma.